by Andrew Berks | Jun 10, 2019 | Blog
The Hatch-Waxman Act (formally known as the Drug Price Competition and Patent Term Restoration Act) is a law passed in 1984 that created the generic drug industry as we know it today in the United States. The Hatch-Waxman Act was created in response to a court case...
by Andrew Berks | Jun 10, 2019 | Blog
{3:00 minutes to read} A patent gives the patent owner the ability to exclude someone else from practicing the claimed invention, which can lead to market exclusivity if a product is within the scope of an issued patent claim. But an important strategic option could...
by Andrew Berks | Jun 10, 2019 | Blog
United Cannabis (UCann) owns US Patent 9,730,911, which discloses methods of extracting cannabinoid oils from cannabis plant material and formulations of the oils. The patent has 36 claims, all on various formulations of cannabinoids. Of particular interest is claim...
